145 related articles for article (PubMed ID: 12622713)
21. Loss of heterozygosity in (LewisxF344)F1 rat urinary bladder tumors induced with N-butyl-N-(4-hydroxybutyl)nitrosamine followed by dimethylarsinic acid or sodium L-ascorbate.
Chen T; Na Y; Wanibuchi H; Yamamoto S; Lee CC; Fukushima S
Jpn J Cancer Res; 1999 Aug; 90(8):818-23. PubMed ID: 10543252
[TBL] [Abstract][Full Text] [Related]
22. [Effect of UFT on urinary bladder tumors in rats induced by N-butyl-N-(4-hydroxybutyl)nitrosamine].
Samma S; Tabata S; Nakatsuji F; Yoshie T; Moriya A; Matsuki H; Watanabe S; Babaya K; Hirao Y; Okajima E
Gan To Kagaku Ryoho; 1985 Aug; 12(8):1661-8. PubMed ID: 3927848
[TBL] [Abstract][Full Text] [Related]
23. Chemopreventive effects of a flavonoid antioxidant silymarin on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in male ICR mice.
Vinh PQ; Sugie S; Tanaka T; Hara A; Yamada Y; Katayama M; Deguchi T; Mori H
Jpn J Cancer Res; 2002 Jan; 93(1):42-9. PubMed ID: 11802807
[TBL] [Abstract][Full Text] [Related]
24. Effect of lupeol on antioxidants and xenobiotic enzymes in N-Butyl-N-(4-hydroxybutyl) nitrosamine induced bladder carcinogenesis in experimental rats.
Prabhu B; Sivakumar A; Balakrishnan D; Sundaresan S
J Exp Ther Oncol; 2017 Sep; 11(2):139-416. PubMed ID: 28976137
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of N-butyl-N-(4-hydroxybutyl) nitrosamine-induced urinary bladder tumor in rats by alpha-difluoromethylornithine.
Kawahara M; Matsuhashi T; Yagishita T; Tajima M; Matsushima M
Hinyokika Kiyo; 1987 Jan; 33(1):27-30. PubMed ID: 3107357
[TBL] [Abstract][Full Text] [Related]
26. Chemopreventive efficacy of piroxicam administered alone or in combination with lycopene and beta-carotene on the development of rat urinary bladder carcinoma after N-butyl-N-(4-hydroxybutyl)nitrosamine treatment.
Okajima E; Ozono S; Endo T; Majima T; Tsutsumi M; Fukuda T; Akai H; Denda A; Hirao Y; Okajima E; Nishino H; Nir Z; Konishi Y
Jpn J Cancer Res; 1997 Jun; 88(6):543-52. PubMed ID: 9263531
[TBL] [Abstract][Full Text] [Related]
27. Preventive but not curative efficacy of celecoxib on bladder carcinogenesis in a rat model.
Sereno J; Parada B; Reis F; Cunha FX; Teixeira-Lemos E; Garrido P; Pinto R; Rocha-Pereira P; Neto P; Ruivo J; Rodrigues-Santos P; Nunes S; Mota A; Figueiredo A; Teixeira F
Mediators Inflamm; 2010; 2010():380937. PubMed ID: 21403827
[TBL] [Abstract][Full Text] [Related]
28. Inhibitory effect of tomato juice on rat urinary bladder carcinogenesis after N-butyl-N-(4-hydroxybutyl)nitrosamine initiation.
Okajima E; Tsutsumi M; Ozono S; Akai H; Denda A; Nishino H; Oshima S; Sakamoto H; Konishi Y
Jpn J Cancer Res; 1998 Jan; 89(1):22-6. PubMed ID: 9510471
[TBL] [Abstract][Full Text] [Related]
29. N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder cancer in C57BL/6 X DBA/2 F1 mice as a useful model for study of chemoprevention of cancer with retinoids.
Becci PJ; Thompson HJ; Strum JM; Brown CC; Sporn MB; Moon RC
Cancer Res; 1981 Mar; 41(3):927-32. PubMed ID: 7459879
[TBL] [Abstract][Full Text] [Related]
30. Chemopreventive effects of cyclooxygenase-2 inhibitor and epidermal growth factor-receptor kinase inhibitor on rat urinary bladder carcinogenesis.
Hattori K; Iida K; Joraku A; Tsukamoto S; Akaza H; Oyasu R
BJU Int; 2006 Mar; 97(3):640-3. PubMed ID: 16469040
[TBL] [Abstract][Full Text] [Related]
31. Chemopreventive effect of omega-3 polyunsaturated fatty acids and atorvastatin in rats with bladder cancer.
El-Ashmawy NE; Khedr EG; El-Bahrawy HA; Al-Tantawy SM
Tumour Biol; 2017 Feb; 39(2):1010428317692254. PubMed ID: 28218036
[TBL] [Abstract][Full Text] [Related]
32. Effects of sex hormones on oncogenesis in rat urinary bladder by N-butyl-N-(4-hydroxybutyl)-nitrosamine.
Tanahashi NK; Suzawa N; Azuma C
Int J Clin Pharmacol Biopharm; 1977 Mar; 15(3):101-5. PubMed ID: 844928
[TBL] [Abstract][Full Text] [Related]
33. Cataracts in rats given a bladder carcinogen, N-butyl-N-(4-hydroxybutyl)-nitrosamine.
Fujita J; Yoshida O; Fujita H; Mikuni I
Tokai J Exp Clin Med; 1983 Nov; 8(4):359-63. PubMed ID: 6679940
[TBL] [Abstract][Full Text] [Related]
34. The effects of catechol on the urinary bladder of rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
La Voie EJ; Shigematsu A; Mu B; Rivenson A; Hoffmann D
Jpn J Cancer Res; 1985 Apr; 76(4):266-71. PubMed ID: 3924700
[TBL] [Abstract][Full Text] [Related]
35. DNA cytophotometric and histological analysis of N-butyl-N-(4-hydroxybutyl)nitrosamine-induced precancerous lesions of the bladder urothelium.
Dahm HH; von der Haar C; Rübben H
J Cancer Res Clin Oncol; 2016 Jun; 142(6):1253-60. PubMed ID: 27033373
[TBL] [Abstract][Full Text] [Related]
36. Combined effects of L-ascorbic acid, citric acid or their sodium salts on tumor induction by N-butyl-N-(4-hydroxybutyl)nitrosamine or N-ethyl-N-(4-hydroxybutyl)nitrosamine in the rat urinary bladder.
Inoue T; Imaida K; Suzuki E; Okada M; Fukushima S
Cancer Lett; 1988 Jun; 40(3):265-73. PubMed ID: 3383181
[TBL] [Abstract][Full Text] [Related]
37. Inhibitory effect of 13-cis-retinoic acid on urinary bladder carcinogenesis induced in C57BL/6 mice by N-butyl-N-(4-hydroxybutyl)-nitrosamine.
Becci PJ; Thompson HJ; Grubbs CJ; Squire RA; Brown CC; Sporn MB; Moon RC
Cancer Res; 1978 Dec; 38(12):4463-6. PubMed ID: 719631
[TBL] [Abstract][Full Text] [Related]
38. Antitumour effects of the angiogenesis inhibitor AGM-1470 on rat urinary bladder tumours induced by N-butyl-N-(4-hydroxybutyl) nitrosamine.
Osawa S; Terashima Y; Kimura G; Akimoto M
BJU Int; 1999 Jan; 83(1):123-8. PubMed ID: 10233464
[TBL] [Abstract][Full Text] [Related]
39. Chemoprevention of mouse urinary bladder carcinogenesis by the naturally occurring carotenoid astaxanthin.
Tanaka T; Morishita Y; Suzui M; Kojima T; Okumura A; Mori H
Carcinogenesis; 1994 Jan; 15(1):15-9. PubMed ID: 8293542
[TBL] [Abstract][Full Text] [Related]
40. Dose response of saccharin in induction of urinary bladder hyperplasias in Fischer 344 rats pretreated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Nakanishi K; Hagiwara A; Shibata M; Imaida K; Tatematsu M; Ito N
J Natl Cancer Inst; 1980 Nov; 65(5):1005-10. PubMed ID: 6933236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
